Trial Profile
Budesonide/formoterol vs budesonide in Chinese patients with moderate-to-very-severe COPD
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Nov 2011
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Budesonide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 18 Nov 2011 New trial record
- 27 Oct 2011 Results presented at the 77th Annual Meeting of the American College of Chest Physicians: Chest 2011.